| Authors: |
Peccatori N; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Locatelli F; Department of Hematology, Oncology and of Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesú, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy., Ammerlaan ACJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands., Jiang Y; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Netherlands., Lissat A; Department of Pediatric Oncology Hematology, Charité- Universitätsmedizin Berlin, Berlin, Germany., Nilsson A; Pediatric Oncology and Hematology, Karolinska University Hospital, Stockholm., Bielorai B; Division of Pediatric Hematology and Oncology, Sheba Medical Center, Ramat-Gan, Israel., Moerloose B; Department of Pediatric Hematology-Oncology Ghent University Hospital, Ghent, Belgium., Rives S; Institut de Recerca Sant Joan de Déu, Barcelona, Spain; Leukemia and Lymphoma Department, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain., Rubio-San-Simon A; Department of Pediatric Oncology and Hematology, Hospital Niño Jesús, Madrid, Spain., Dirksen U; Pediatrics III, West German Cancer Center, National Center for Tumor diseases, German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Engstler G; St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Bruno B; Paediatric hematology, CHU Lille, Lille, France., Diaz-de-Heredia C; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall D'Hebron, Barcelona, Spain; Institut de Recerca Vall d'Hebron, Barcelona, Spain., Brethon B; Pediatric Hematology and Immunology Department, Robert Debré Academic Hospital, GHU AP-HP Nord Université Paris Cité, Paris, France., Sirvent FB; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Rialland F; Service Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes, France., Sramkova L; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic., Pasquet M; Department of Pediatric Hematology, Children's Hospital, Toulouse University Hospital, Toulouse, France., Nysom K; Department of Paediatrics and Adolescent Medicine, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Bertorello N; Paediatric Onco-Haematology Department, Regina Margherita Children's Hospital, University of Turin, Turin, Italy., Bader P; Department of Pediatrics, Division for Stem Cell Transplantation, Immunology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway., van der Sluis IM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Beverloo B; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Netherlands., Sleight B; Pfizer, Groton, CT, USA., Stackelberg AV; Department of Pediatric Oncology Hematology, Charité- Universitätsmedizin Berlin, Berlin, Germany., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands., Brivio E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Electronic address: e.b.brivio@prinsesmaximacentrum.nl. |
